Varian, a Siemens Healthineers Company

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Varian, a Siemens Healthineers Company sits in the top decile of US sponsors by registered trial count (#886 of 15,742 sponsors by registered trial count).

16 total trials 5 currently recruiting 7 completed top decile by trial count

Varian, a Siemens Healthineers Company: 16 sponsored US clinical trials, 5 recruiting.

Varian, a Siemens Healthineers Company sponsors 16 registered US clinical trials on ClinicalTrials.gov, 5 of them currently recruiting, and 7 completed. The most-studied condition in this pipeline is Pelvic Cancer, with 2 trials.

Top-decile sponsor footprint

Varian, a Siemens Healthineers Company ranks in the top decile of sponsors by registered trial count (#886 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Open and recent trials

16 total, page 1 of 1

RECRUITING NA

Feasibility Study of CBCT for IGRT in Cancer Patients

NCT06681233

RECRUITING NA

Stereotactic Adaptive Radiation Therapy of Borderline Resectable Pancreatic Cancer an Individualized Approach

NCT05764720

RECRUITING NA

Cardiac RADIoablation Versus Repeat Catheter Ablation: a Pivotal Randomized Clinical Trial Evaluating Safety and Efficacy for Patients With High-risk Refractory Ventricular Tachycardia (RADIATE-VT)

NCT05765175

RECRUITING NA

Daily Adaptive Radiation Therapy Using an Individualized Approach for Prostate Cancer

NCT05804318

RECRUITING NA

Daily Adaptive Radiation Therapy an Individualized Approach for Carcinoma of the Cervix

NCT05197881

ACTIVE NOT RECRUITING NA

Evaluation of Improved Onboard Patient Imaging

NCT06187103

ACTIVE NOT RECRUITING NA

A Prospective Imaging Study of the Integrated TrueBeam-HyperSight CBCT System

NCT05975619

ACTIVE NOT RECRUITING NA

FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases in the Thorax

NCT05524064

TERMINATED NA

Daily Online Adaptive Short-Course Radiation Therapy and Concurrent Chemotherapy for Muscle-Invasive Bladder Cancer

NCT05700227

COMPLETED

HyperArc Registry Study

NCT05270707

COMPLETED NA

Feasibility Study of FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases

NCT04592887

COMPLETED NA

CyberHeart's Cardiac Arrhythmia Ablation Treatment: Patients With Refractory Ventricular Tachycardia/Fibrillation

NCT02661048

COMPLETED NA

Evaluating an Anchored Transponder in Lung Cancer Patients Receiving Radiation Therapy

NCT01396551

COMPLETED

CMT-07-08: The PROstate Bed Evaluation Study

NCT00763152

COMPLETED

The AIM Study: Assessing the Impact of Margin Reduction

NCT00754000

COMPLETED NA

Positioning and Tracking the Prostate During External Beam Radiation

NCT00123838

What is open in the Varian, a Siemens Healthineers Company pipeline

5 recruiting of 16 indexed (31% open); 7 completed (44%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Pelvic Cancer (2 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Varian, a Siemens Healthineers Company: open-pipeline peers nationwide

Peers matched on 16 registered trials and 31% open enrollment, not the therapeutic-area sidebar.

Varian, a Siemens Healthineers Company sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 1020304050 0%10%20%30%40% Total trials Recruiting share Varian, a Siemens Healthineers CompanyAccelerated Community Oncology Research NetworkAltimmuneAmerican UniversityAnthera PharmaceuticalsEko DevicesWright State UniversityLaureate Institute for Brain ResearchPhilips Clinical & Medical Affairs Global
Varian, a Siemens Healthineers Company sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Varian, a Siemens Healthineers Company sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 16 trials (± recruiting share)

Sponsors near 31% open enrollment (± trial volume)

What to do with this Varian, a Siemens Healthineers Company page

16 registered trials is a research-attention snapshot, not an endorsement of Varian, a Siemens Healthineers Company or any single study.

  • 5 of Varian, a Siemens Healthineers Company's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Pelvic Cancer is the condition Varian, a Siemens Healthineers Company studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Pelvic Cancer trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Varian, a Siemens Healthineers Company pipeline card: 16 registered trials from official public datasets.Report a data error.